SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-025927
Filing Date
2021-05-13
Accepted
2021-05-13 08:30:52
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea140472-s3_citiuspharma.htm S-3 313882
2 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP ea140472ex5-1_citiuspharma.htm EX-5.1 5740
3 CONSENT OF WOLF & COMPANY, P.C. ea140472ex23-1_citiuspharma.htm EX-23.1 2934
4 GRAPHIC image_001.jpg GRAPHIC 13550
  Complete submission text file 0001213900-21-025927.txt   342523
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-256063 | Film No.: 21917349
SIC: 2834 Pharmaceutical Preparations